Buchacz Kate, McFarland Willi, Kellogg Timothy A, Loeb Lisa, Holmberg Scott D, Dilley James, Klausner Jeffrey D
Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
AIDS. 2005 Sep 2;19(13):1423-4. doi: 10.1097/01.aids.0000180794.27896.fb.
We examined the association between amphetamine use and HIV incidence for 2991 men who have sex with men (MSM) who tested anonymously for HIV in San Francisco. HIV incidence among 290 amphetamine users was 6.3% per year (95% CI 1.9-10.6%), compared with 2.1% per year (95% CI 1.3-2.9%) among 2701 non-users (RR 3.0, 95% CI 1.4-6.5). HIV prevention programmes in San Francisco should include efforts to reduce amphetamine use and associated high-risk sexual behaviors.
我们对在旧金山进行匿名HIV检测的2991名男男性行为者(MSM)中使用安非他命与HIV发病率之间的关联进行了研究。290名安非他命使用者中的HIV发病率为每年6.3%(95%置信区间1.9 - 10.6%),相比之下,2701名非使用者中的发病率为每年2.1%(95%置信区间1.3 - 2.9%)(相对风险3.0,95%置信区间1.4 - 6.5)。旧金山的HIV预防项目应包括减少安非他命使用及相关高危性行为的努力。